Gamma probe

Global $1.66 Bn Glaucoma Surgery Devices Market, (2021-2026) - Increasing Innovations and Technological Development in Glaucoma Surgical Devices Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, February 18, 2022

The Global Glaucoma Surgery Devices Market is segmented further based on Product, Surgery Type, End-User, and Geography.

Key Points: 
  • The Global Glaucoma Surgery Devices Market is segmented further based on Product, Surgery Type, End-User, and Geography.
  • By Product, the market is classified as Punches, USC Marker, USC Planner, USC Shaver, Forceps, Algerbrush, Probes, Diamond Knives, Glaucoma Drainage Device, Laser System, and Others.
  • By Surgery Type, the market is classified as Traditional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery, and Laser Surgery.
  • Iridex Corporation has entered into a strategic collaboration with Topcon Corporation to drive expanded market penetration of Iridex's unique non-incisional glaucoma therapy products.

Breast Lesion Localization Methods Market Worth 5750.9 Thousands of Procedures by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, July 16, 2020

The overall market for breast lesion localization methods market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer.

Key Points: 
  • The overall market for breast lesion localization methods market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer.
  • Based on type, the breast lesion localization methods market is divided into wire localization, isotope localization, magnetic localization, electromagnetic localization, and others.
  • The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2019.
  • By usage, the breast lesion localization methods market is segmented into tumor identification and sentinel lymph node identification.The sentinel lymph node identification segment is further divided by types of surgery into lumpectomy and mastectomy.The sentinel lymph node identification segment dominated thebreast lesion localization methods market in 2019.

Breast Lesion Localization Methods Market Worth 5750.9 Thousands of Procedures by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, July 16, 2020

The overall market for breast lesion localization methods market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer.

Key Points: 
  • The overall market for breast lesion localization methods market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer.
  • Based on type, the breast lesion localization methods market is divided into wire localization, isotope localization, magnetic localization, electromagnetic localization, and others.
  • The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2019.
  • By usage, the breast lesion localization methods market is segmented into tumor identification and sentinel lymph node identification.The sentinel lymph node identification segment is further divided by types of surgery into lumpectomy and mastectomy.The sentinel lymph node identification segment dominated thebreast lesion localization methods market in 2019.

Castle Biosciences Presents Second Study Confirming Ability of DecisionDx-Melanoma to Inform Sentinel Lymph Node Biopsy Decisions at the 8th International Congress on Cancer Metastasis

Retrieved on: 
Monday, October 28, 2019

The study found that DecisionDx-Melanoma test results can be used with clinicopathologic factors to identify patients at low risk of sentinel lymph node (SLN) positivity.

Key Points: 
  • The study found that DecisionDx-Melanoma test results can be used with clinicopathologic factors to identify patients at low risk of sentinel lymph node (SLN) positivity.
  • This information can inform patient discussions and recommendations regarding the SLNB surgical procedure in line with national melanoma clinical practice guidelines.
  • National guidelines recommend the SLNB surgical procedure to assess prognosis of melanoma patients whose tumor features suggest at least a 5% likelihood of sentinel lymph node (SLN) positivity.
  • The guidelines do not recommend the procedure if a patient has a likelihood of SLN positivity of less than 5%.